Randomized, Controlled, Phase 1 Study to Assess Safety and Immunogenicity of Co-administered Hookworm Vaccine Candidates Na-APR-1 (M74)/Alhydrogel® and Na-GST-1/ Alhydrogel® in Gabonese Children

Trial Profile

Randomized, Controlled, Phase 1 Study to Assess Safety and Immunogenicity of Co-administered Hookworm Vaccine Candidates Na-APR-1 (M74)/Alhydrogel® and Na-GST-1/ Alhydrogel® in Gabonese Children

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 May 2017

At a glance

  • Drugs Glycopyranosyl lipid adjuvant (Primary) ; Hookworm vaccine (Primary) ; Hepatitis B vaccine
  • Indications Hookworm infections
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Apr 2017 Planned End Date changed from 1 Nov 2017 to 1 Oct 2018.
    • 06 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Nov 2017.
    • 06 Apr 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top